Project Grant R41MH134704
Award Date
9/1/23
Completion Date
8/31/25
Dollars Obligated
$1.1M
Federal Agency
National Institute of Mental Health
Federal Grant Program
93.242
Assistance Type
Project Grant
Place of Performance
Connecticut, USA
Similar Awards
The National Institute of Mental Health (NIMH), through its Mental Health Research Grants program (CFDA 93.242), awarded a $249,521 project grant to the University of Kansas Center for Research Inc. The grant, titled "Building Healthy Eating and Self-Esteem Together for University Students (BEST-U): A Pilot Randomized Controlled Trial of an mHealth Intervention for Binge-Spectrum Disorders," will fund a pilot study to test the effectiveness of a mobile health (mHealth)...
This Project Grant award, with a total funding amount of $958,629, was awarded by the National Institute on Drug Abuse (NIDA) under the Drug Abuse and Addiction Research Programs (CFDA 93.279). The funding will support the real-world adoption of an innovative digital health therapeutic called KIOS, which uses nonlinear control theory to track multiple symptoms (e.g., craving, mood, pain) and deliver personalized, evidence-based intervention strategies to patients with opioid use disorder...
This Project Grant award of $386,266 from the National Institute of Mental Health (NIMH) Mental Health Research Grants program (CFDA 93.242) is for the development and assessment of a digital health platform called "CLUTTER-GO" to facilitate delivery and adherence to evidence-based cognitive-behavioral therapy (CBT) for hoarding disorder.
The CLUTTER-GO platform will consist of a clinician portal and patient-facing mobile app designed to improve adherence to CBT homework assignments...
The federal Project Grant award of $1,948,634 from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) will support the development and evaluation of an mHealth (mobile health) intervention called "OD-CHESS" to reduce overdose risk among people who engage in polysubstance use.
In the initial R61 phase, the project will adapt an existing smartphone-based substance use disorder intervention (A-CHESS) into OD-CHESS, in partnership with people...
This Project Grant award from the National Institutes of Health's Drug Use and Addiction Research Programs (CFDA 93.279) provides $1,594,478 to the University of Massachusetts Medical School to conduct a 5-year study on using digital biomarkers of craving to improve outcomes for individuals with opioid use disorder (OUD) receiving medications for OUD (MOUD) treatment.
The key products and services to be delivered include: 1) curating a high-quality dataset of craving patterns during MOUD...
This $631,896 R01 grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) will fund a 5-year study to compare the effectiveness of different remote-based behavioral weight loss interventions. The project, titled "Comparison of Behaviorally-Based Remote Approaches to Optimize Weight Loss and Identification of Factors which Characterize Treatment Response", will...
This Project Grant award from the National Institute of Mental Health (CFDA 93.242 Mental Health Research Grants) will support the optimization of an automated chatbot to deliver efficient, scalable treatment for eating disorders. The $1,682,938 award to The Washington University will fund a 4-year optimization randomized control trial to test 4 key components of the chatbot intervention, including modules targeting weight/shape overvaluation, dietary restraint, emotion dysregulation, and...
This Project Grant award of $1,076,018 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will support a clinical trial to evaluate the efficacy of a digital therapeutic called DCH-003 for the treatment of stimulant use disorders (STUD).
DCH-003 is a prescription digital therapeutic developed by Dynamicare Health Inc. that delivers contingency management (CM) and other evidence-based modalities through a mobile app. The proposed...
This $445,000 Project Grant awarded by the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports the development and pilot testing of a novel telehealth and mobile health (mHealth) intervention called MOMENT-V for young adults with cannabis use disorder (CUD).
The MOMENT-V intervention combines telehealth motivational enhancement therapy (MET) with mHealth ecological momentary intervention (EMI) to provide a fully remote brief...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under CFDA Program 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research, supports a $674,391 study to develop and validate a phenotype-tailored lifestyle intervention (PLI) for obesity treatment. The project aims to:
Compare the outcomes of the PLI versus a standard lifestyle intervention (SLI) program in a 12-month randomized clinical trial with adult obesity...